Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company dedicated to the discovery and development of drugs. Its platform technology of protein engineering enables the development of small molecule and macromolecular drugs as well as antibody drug conjugates for the treatment of cancer, autoimmune, and metabolic diseases. In addition, the company engages in the development of biologic drug candidates to treat tumors, psoriasis, multiple sclerosis, osteoporosis, migraine, etc.